Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

SMMT - Summit Therapeutics Inc. Financial... | Finranks

Home

/

SMMT

S

Summit Therapeutics Inc. (SMMT)

NGM – Real Time Price. Currency in USD

15.18

+0.06 (0.40%)

Market open: Aug 12, 2026, 3:27 PM EDT

15.19

+0.07 (0.50%)

Previous after-hours: Aug 11, 2026, 7:55 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

705K

Cost of goods sold

-146K

-89K

-2M

-3M

Gross Profit

-146K

-89K

-2M

-2M

Operating expenses (excl. COGS)

-1.09B

-211M

-88M

-77M

Operating Income

-1.09B

-211M

-90M

-79M

Non-operating income, total

15M

-10M

-526M

-4M

Pretax income

-1.08B

-222M

-616M

-83M

Equity in earnings

0

0

0

0

Taxes

0

313K

946K

5M

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-1.08B

-221M

-615M

-79M

Discontinued operations

0

0

0

0

Net income

-1.08B

-221M

-615M

-79M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

751M+72.5%

436M+114.6%

203M-69.4%

664M

Total current assets

720M

424M

190M

657M

Total non-current assets

31M

12M

13M

7M

Total liabilities

92M+97.2%

47M-62.6%

125M-76.7%

538M

Total current liabilities

73M

42M

20M

39M

Total non-current liabilities

19M

5M

105M

499M

Total equity

659M

389M

78M

127M

Total liabilities & shareholders' equities

751M

436M

203M

664M

Total debt

21M+189.4%

7M-93.2%

106M-79.5%

519M

Name

2025

2024

2023

2022

Cash from operating activities

-323M

-142M

-77M

-42M

Cash from investing activities

-174M

-205M

-588M

-624K

Cash from financing activities

618M

381M

87M

620M

Free cash flow

-324M-127.5%

-142M-85.0%

-77M-82.2%

-42M